Sun Yat-Sen University, Hubei University, and GeneMedi co-published a scientific paper on a COVID-19 vaccine in the prestigious Nature Group Journal.
Read The Paper
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein & Antibody Innovation for more reliable diagnostic solutions.
GTU empowers self-capabilities for application development to develop more powerful products and solutions to meet the needs of the biologics industry.
GTU & G-NEXT combine the novel AAV rational design, smart discovery, and State-of-the-Art manufacturing to meet the industrial unmet needs for the next generation of gene therapy.
Pre-made and custom-made recombinant proteins (Antibodies, Enzymes, Membrane protein, Factors and other antigens) for drug discovery and diagnostics ingredients. High quality, bulk in stock.
Membrane Protein & antibodies artificial design, discovery, and State-of-the-Art Manufacturing.
INN-Index, bispecific, ADC, nanobody, cytokine, Neutralizing, etc
Anti-MMAE, VLP, FcR, Target Expression vector, etc
IO Target, T cell, NK, Macrophage, specific TAA Target, TME
A unique big-data-driven mature antibody humanization technology to balance high affinity with low immunogenicity for your parental antibodies.
High quality, scalable, State-of-the-Art Manufacturing in gene therapy vectors including adenoassociated virus (AAV) vector, lentivirus vector and adenovirus vector.
Facebook
LinkedIn
Twitter